Digital Dyadic Empowerment Program on Lifestyle Modification for Chronic Kidney Disease Management
NCT06756113 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 208
Last updated 2026-02-12
Summary
The goal of this clinical trial is to find out if the Digital Dyadic Empowerment Program (DDEP) can help people with chronic kidney disease (CKD) and their care partners make healthy lifestyle changes. The main questions this study will answer are:
* Does DDEP help protect kidney function?
* Does DDEP support healthier daily habits?
Researchers will compare two groups:
* One group will receive the DDEP and get usual medical care.
* The other group will get usual medical care only.
Participants will:
* Receive usual care with or without DDEP for six months.
* Visit the clinic at the start and end of the study for health checks and tests.
* Practice healthy habits at home with or without help from DDEP.
This study aims to show if adding DDEP to regular care can make it easier for people with CKD and their care partners to live healthier lives.
Conditions
- Chronic Kidney Diseases
Interventions
- BEHAVIORAL
-
Digital Dyadic Empowerment
The Digital Dyadic Empowerment Intervention utilizes LINE, a prominent instant messaging App in Taiwan, integrated with an extended application to deliver comprehensive lifestyle modification support to Chronic Kidney Disease (CKD) dyads. Key features of this intervention include: 1. Access to CKD Health Education Information; 2. Supportive Information for Significant Others; 3. Physiological Values Logging for Self-Monitoring; 4. Reminders for Clinical Appointments and Daily Self-Management Tasks; 5. Kidney Health Diary for Lifestyle Modification Progress Tracking; 6. Frequently Asked Questions (FAQs) and Consultation with Healthcare Providers. This intervention aims to enhance the overall well-being of CKD dyads by promoting education, self-monitoring, adherence to appointments, and efficient communication with healthcare providers.
- BEHAVIORAL
-
Usual Care
All patients in this study received regular nephrology care at National Cheng Kung University Hospital. Nephrologists conducted routine examinations and provided diagnoses based on test results. The patient's condition (e.g., changes in kidney function), treatment plan, prognosis, and risks were explained to both the patient and family members. The treatment plan included medication, monitoring blood pressure, dietary and exercise at home, and consultations with the Health Education Center for kidney care or nutrition advice.
Sponsors & Collaborators
-
National Health Research Institutes, Taiwan
collaborator OTHER -
National Cheng Kung University
lead OTHER
Principal Investigators
-
Miaofen Yen, PhD · National Cheng Kung University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-13
- Primary Completion
- 2025-10-08
- Completion
- 2025-10-15
Countries
- Taiwan
Study Locations
More Related Trials
-
Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
NCT06560801 ·Status: RECRUITING ·Phase: PHASE4
-
Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients
NCT06101901 ·Status: NOT_YET_RECRUITING
-
Decision Impact Trial of KidneyIntelX
NCT04791358 ·Status: RECRUITING
-
Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)
NCT01829256 ·Status: COMPLETED ·Phase: NA
-
Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)
NCT02176278 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults
NCT05881213 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes
NCT00976495 ·Status: COMPLETED ·Phase: PHASE2
-
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
NCT01572610 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients With Nephropathy
NCT00309127 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
NCT06140537 ·Status: RECRUITING ·Phase: PHASE4
-
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
NCT06717698 ·Status: RECRUITING ·Phase: PHASE2
-
Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy
NCT00253786 ·Status: COMPLETED ·Phase: NA
-
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
NCT05719714 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Replication of the DAPA-CKD (Chronic Kidney Disease) Trial in Healthcare Claims Data
NCT04882813 ·Status: COMPLETED
-
A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease
NCT04750577 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease
NCT06610526 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Type 2 Diabetes Patients With Renal Impairment
NCT04221399 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate EDG-7500 in People With Renal Impairment
NCT07034768 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT01500798 ·Status: TERMINATED ·Phase: PHASE1
-
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
NCT05198284 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Decision Impact Trial of KidneyIntelX
NCT04960514 ·Status: ACTIVE_NOT_RECRUITING
-
Integrated Population Program for Diabetic Kidney Disease
NCT02418091 ·Status: COMPLETED ·Phase: NA
-
An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea
NCT07232537 ·Status: RECRUITING
-
Diabetic Patients With End-Stage Renal Disease
NCT00435786 ·Status: COMPLETED
-
Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers
NCT06709807 ·Status: COMPLETED ·Phase: PHASE1